Abstract Library

#1527 Induction and Maintenance Regimen with Peptide Receptor Radionuclide Therapy (PRRT) Lu-177-DOTA-TATE (Lu-177) in Patients with Advanced Neuroendocrine Tumours (NET).

Introduction: PRRT using Lu-177 is a treatment option for advanced NETs.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Mc Ewan A, Wieler M, Makis W, McMullen T, Morrish D,

Keywords: neuroendocrine, Lu-177-DOTA-TATE,

#1227 Molecular Profiling of Small Intestinal Neuroendocrine Tumours (SINETs)

Introduction: Aberrant DNA methylation plays an role in the pathogenesis of many cancers, however little is known about its role in SINET development.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Thirlwell C

Authors: Karpathakis A, Feber A, Morris T, Dibra H, Pipinikas C,

Keywords: Epigenetics, methylation, GIPR, biomarker,

#1106 Salvage Treatment with Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Advanced VIPomas and Severe Verner-Morrison Syndrome

Introduction: PRRT is an effective treatment option for advanced Neuroendocrine Tumours

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Yalchin M, Gertner J, Navalkissoor S, Quigley A, Meyer T,

Keywords: PRRT VIP,

#936 Promoter Hypermethylation at RASSF1 is a Feature of Small Intestinal Neuroendocrine Tumors

Introduction: Promoter hypermethylation of RASSF1 has been reported in many tumor types.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Karpathakis A

Authors: Karpathakis A, Dibra H, Morris T, Feber A, Mandair D,

Keywords: Epigenetics, methylation, RASSF1,